PMitCEBO protocol

chemotherapy protocol consisting of above compounds; used in the treatment of recurrent non-Hodgkin's lymphoma

Also Known As:

PMitCEBO

Networked: 6 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - PMitCEBO protocol: 6
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - PMitCEBO protocol: 6
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - PMitCEBO protocol: 6
Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - Etoposide: 10706
      - PMitCEBO protocol: 6
- Glycoconjugates: 1353
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - PMitCEBO protocol: 6
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - PMitCEBO protocol: 6
Organic Chemicals: 133
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        PMitCEBO protocol: 6
  - Anthracenes: 12
    - Anthrones: 12
      - Anthraquinones: 788
        Mitoxantrone: 2907
        PMitCEBO protocol: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Prednisolone: 12013
        PMitCEBO protocol: 6
Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        Vincristine: 9251
        PMitCEBO protocol: 6
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        PMitCEBO protocol: 6
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        Vincristine: 9251
        PMitCEBO protocol: 6

Experts

1.	Cunningham, D: 2 articles (03/2006 - 05/2001)
2.	Hancock, B: 2 articles (03/2006 - 05/2001)
3.	Hoskin, P: 2 articles (03/2006 - 05/2001)
4.	Linch, D: 2 articles (03/2006 - 05/2001)
5.	MacLennan, K: 2 articles (03/2006 - 05/2001)
6.	Smith, P: 2 articles (03/2006 - 05/2001)
7.	Abgral, Ronan: 1 article (12/2021)
8.	Berthou, Christian: 1 article (12/2021)
9.	Guillerm, Gaëlle: 1 article (12/2021)
10.	Ianotto, Jean-Christophe: 1 article (12/2021)

Related Diseases

1.	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/01/1997 - "Weekly chemotherapy using PMitCEBO in the palliation of recurrent non-Hodgkin's lymphoma." 05/18/2009 - "Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO." 03/27/2006 - "A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma." 01/01/2009 - "A 69-year-old gentleman with non-Hodgkin's lymphoma (stage I), with baseline fibrotic lung changes on CT, received six cycles of R-PMitCebo chemotherapy containing bleomycin. " 05/15/2001 - "Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO."
2.	Lymphoma (Lymphomas) 05/18/2009 - "Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO."
3.	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/01/2021 - "Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. "

Related Drugs and Biologics

1.	Mitoxantrone (Novantrone)
2.	Doxorubicin (Adriamycin)
3.	Granulocyte Colony-Stimulating Factor (G-CSF)
4.	Bleomycin (Blenoxane)
5.	Rituximab (Mabthera)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)